JP5646990B2 - 幹細胞自己複製のための方法及び組成物 - Google Patents

幹細胞自己複製のための方法及び組成物 Download PDF

Info

Publication number
JP5646990B2
JP5646990B2 JP2010506243A JP2010506243A JP5646990B2 JP 5646990 B2 JP5646990 B2 JP 5646990B2 JP 2010506243 A JP2010506243 A JP 2010506243A JP 2010506243 A JP2010506243 A JP 2010506243A JP 5646990 B2 JP5646990 B2 JP 5646990B2
Authority
JP
Japan
Prior art keywords
pten
inhibitor
cells
gsk
hsc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010506243A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010524499A5 (cg-RX-API-DMAC7.html
JP2010524499A (ja
Inventor
エム. ペリー,ジョン
エム. ペリー,ジョン
リ,リンヘン
シー. グリンドリー,ジャスティン
シー. グリンドリー,ジャスティン
Original Assignee
ストワーズ インスティテュート フォー メディカル リサーチ
ストワーズ インスティテュート フォー メディカル リサーチ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ストワーズ インスティテュート フォー メディカル リサーチ, ストワーズ インスティテュート フォー メディカル リサーチ filed Critical ストワーズ インスティテュート フォー メディカル リサーチ
Publication of JP2010524499A publication Critical patent/JP2010524499A/ja
Publication of JP2010524499A5 publication Critical patent/JP2010524499A5/ja
Application granted granted Critical
Publication of JP5646990B2 publication Critical patent/JP5646990B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2010506243A 2007-04-23 2008-04-23 幹細胞自己複製のための方法及び組成物 Active JP5646990B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92606507P 2007-04-23 2007-04-23
US60/926,065 2007-04-23
US6669308P 2008-02-22 2008-02-22
US61/066,693 2008-02-22
PCT/US2008/005230 WO2008133904A1 (en) 2007-04-23 2008-04-23 Methods and compositions for stem cell self-renewal

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014125145A Division JP2014195464A (ja) 2007-04-23 2014-06-18 幹細胞自己複製のための方法及び組成物

Publications (3)

Publication Number Publication Date
JP2010524499A JP2010524499A (ja) 2010-07-22
JP2010524499A5 JP2010524499A5 (cg-RX-API-DMAC7.html) 2011-06-23
JP5646990B2 true JP5646990B2 (ja) 2014-12-24

Family

ID=39925972

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010506243A Active JP5646990B2 (ja) 2007-04-23 2008-04-23 幹細胞自己複製のための方法及び組成物
JP2014125145A Pending JP2014195464A (ja) 2007-04-23 2014-06-18 幹細胞自己複製のための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014125145A Pending JP2014195464A (ja) 2007-04-23 2014-06-18 幹細胞自己複製のための方法及び組成物

Country Status (4)

Country Link
US (8) US8263403B2 (cg-RX-API-DMAC7.html)
EP (2) EP2798956A1 (cg-RX-API-DMAC7.html)
JP (2) JP5646990B2 (cg-RX-API-DMAC7.html)
WO (1) WO2008133904A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2798956A1 (en) * 2007-04-23 2014-11-05 Stowers Institute for Medical Research Methods and compositions for hematopoeitic stem cell self-renewal
US20110076254A1 (en) * 2009-09-28 2011-03-31 University Of Washington Porous scaffolds for stem cell renewal
US9050315B2 (en) * 2010-04-12 2015-06-09 The Trustees Of The University Of Pennsylvania In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combination of clinically tested, FDA approved drugs
CN102234627B (zh) * 2010-04-30 2015-06-03 中国科学院广州生物医药与健康研究院 一种培养基添加剂及其应用
WO2011159359A2 (en) 2010-06-17 2011-12-22 Stemrd, Inc. Serum-free chemically defined cell culture medium
WO2012131733A2 (en) * 2011-03-31 2012-10-04 Godavari Biorefineries Limited Media compositions, method of initiating and enriching cultures of stem cells and/or cancer stem-like cells
US9157908B2 (en) 2011-04-22 2015-10-13 University Of Washington Through Its Center For Commercialization Chitosan-alginate scaffold cell culture system and related methods
WO2012175633A1 (en) 2011-06-21 2012-12-27 Novo Nordisk A/S Efficient induction of definitive endoderm from pluripotent stem cells
CN102250830B (zh) * 2011-07-05 2013-01-16 西北农林科技大学 一种雌性生殖干细胞的体外分离及培养方法
JP2014526887A (ja) * 2011-08-01 2014-10-09 アルナイラム ファーマシューティカルズ, インコーポレイテッド 造血幹細胞移植の成功率を改善する方法
US9896659B2 (en) * 2011-10-19 2018-02-20 Stowers Institute For Medical Research Methods, kits, and compositions for stem cell self-renewal
WO2013173688A1 (en) * 2012-05-18 2013-11-21 The Cooper Health System A method of making tissue engineered blood vessels and generating capillary networks, articles, and methods of use thereof
GB201210857D0 (en) 2012-06-19 2012-08-01 Cambridge Entpr Ltd Transcription factor mediated programming towards megakaryocytes
CA2896053A1 (en) 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Methods for production of platelets from pluripotent stem cells and compositions thereof
WO2014144423A2 (en) * 2013-03-15 2014-09-18 Techulon Inc. Antisense molecules for treatment of staphylococcus aureus infection
NZ715302A (en) 2013-06-14 2021-12-24 Univ Queensland Renal progenitor cells
US20150250824A1 (en) * 2014-03-07 2015-09-10 The Research Foundation For The State University Of New York Methods and compositions for expansion of stem cells and other cells
JP6502323B2 (ja) * 2014-03-26 2019-04-17 国立大学法人京都大学 多能性幹細胞培養用培地
CN105441384B (zh) * 2014-09-26 2021-01-05 北京大学 一种制备动物和人类原始多潜能干细胞的方法,试剂盒及用途
EP3263697B1 (en) * 2015-02-27 2021-03-31 Rohto Pharmaceutical Co., Ltd. Culture medium for culturing mesenchymal stem cell, method for culturing mesenchymal stem cell, and mesenchymal stem cell
US20180360025A1 (en) * 2015-07-22 2018-12-20 Ramot At Tel-Aviv University Ltd. Article of manufacture and methods for increasing survival of red blood cells
WO2017079632A1 (en) * 2015-11-04 2017-05-11 Cedars-Sinai Medical Center Patient-derived ctc-xenograft models
WO2017139381A1 (en) 2016-02-08 2017-08-17 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
WO2017155973A1 (en) 2016-03-07 2017-09-14 University Of Iowa Research Foundation Aav-mediated expression using a synthetic promoter and enhancer
US10688136B2 (en) * 2016-05-20 2020-06-23 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions to maintain stem cell quiescence
US12173305B2 (en) 2016-05-26 2024-12-24 University Of Iowa Research Foundation cis and trans requirements for terminal resolution of human bocavirus 1
AU2017335841A1 (en) 2016-09-28 2019-04-04 Organovo, Inc. Use of engineered renal tissues in assays
US11142775B2 (en) 2017-01-13 2021-10-12 University Of Iowa Research Foundation Bocaparvovirus small noncoding RNA and uses thereof
WO2018217567A1 (en) * 2017-05-22 2018-11-29 Transfusion Health, Llc Compositions and methods of making expanded hematopoietic stem cells using pten inhibitors
WO2019074980A1 (en) * 2017-10-09 2019-04-18 Stowers Institute For Medical Research METHODS AND COMPOSITIONS FOR EXPANSION OF CELL POPULATION
EP3700334B1 (en) * 2017-10-27 2026-04-08 Immunebridge Inc. Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene
KR102010922B1 (ko) * 2017-11-01 2019-08-14 가톨릭관동대학교산학협력단 켄파울론 유도체의 줄기세포의 심근세포로의 분화 유도 용도
CN107630002A (zh) * 2017-11-03 2018-01-26 广州市天河诺亚生物工程有限公司 一种脐带血造血干细胞的扩增方法
US20210255170A1 (en) * 2018-03-13 2021-08-19 University Of Iowa Research Foundation Inductive regeneration of the airway by transcriptional factor modulation of glandular myoepithelial stem cells
CN108277203B (zh) * 2018-04-08 2020-07-24 浙江大学 一种体外维持人造血干祖细胞干性的培养基及方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990010448A2 (en) 1989-03-07 1990-09-20 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
WO1991004753A1 (en) 1989-10-02 1991-04-18 Cetus Corporation Conjugates of antisense oligonucleotides and therapeutic uses thereof
US5958769A (en) 1996-01-18 1999-09-28 Fred Hutchinson Cancer Research Center Compositions and methods for mediating cell cycle progression
US5851984A (en) * 1996-08-16 1998-12-22 Genentech, Inc. Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
US6159462A (en) * 1996-08-16 2000-12-12 Genentech, Inc. Uses of Wnt polypeptides
US6962698B1 (en) 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
US7018801B2 (en) 2000-02-11 2006-03-28 Board Of Regents, The University Of Texas System Selection of peptides with antibody-like properties
IL152904A0 (en) 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
CA2495824A1 (en) * 2002-08-19 2004-02-26 Gamida-Cell Ltd. Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures
AU2003295444A1 (en) * 2002-11-15 2004-06-15 The Board Of Trustees Of The University Of Illinois Methods for in vitro expansion of hematopoietic stem cells
US20050054097A1 (en) * 2002-11-17 2005-03-10 Tony Peled EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
AU2003294499A1 (en) 2002-11-25 2004-06-18 Exelixis, Inc. Rhebs as modifiers of the rb pathway and methods of use
EP1601759A4 (en) * 2003-03-07 2007-02-14 Gamida Cell Ltd EXPANSION OF RENEWABLE STEM CELL POPULATIONS USING PI-3 KINASE MODULATORS
US7510877B2 (en) * 2003-09-26 2009-03-31 The Regents Of The University Of Michigan Hematopoietic stem cell identification and isolation
US20070065447A1 (en) 2003-10-29 2007-03-22 Novo Nordisk A/S Laminin-5 gamma2-binding peptides, related compositions, and use thereof
WO2006027545A2 (en) 2004-09-10 2006-03-16 Agency For Science, Technology And Research Method
WO2006030442A2 (en) 2004-09-16 2006-03-23 Gamida-Cell Ltd. Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
US7850960B2 (en) * 2004-12-30 2010-12-14 University Of Washington Methods for regulation of stem cells
EP1705949A1 (en) * 2005-03-22 2006-09-27 Sony Ericsson Mobile Communications AB An electroacoustic device
JP2009532017A (ja) 2006-02-10 2009-09-10 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア PTD/CPPSへのdsRNA結合ドメイン融合体によるsiRNAの導入可能な送達
EP1999255A2 (en) 2006-03-24 2008-12-10 The Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
CN102911989B (zh) * 2006-11-01 2015-07-22 罗格斯,新泽西州立大学 脐带血干细胞增殖和生长因子产生的锂刺激
EP2798956A1 (en) 2007-04-23 2014-11-05 Stowers Institute for Medical Research Methods and compositions for hematopoeitic stem cell self-renewal
US9896659B2 (en) * 2011-10-19 2018-02-20 Stowers Institute For Medical Research Methods, kits, and compositions for stem cell self-renewal

Also Published As

Publication number Publication date
WO2008133904A1 (en) 2008-11-06
US20110053266A1 (en) 2011-03-03
US20100099186A1 (en) 2010-04-22
JP2010524499A (ja) 2010-07-22
EP2798956A1 (en) 2014-11-05
JP2014195464A (ja) 2014-10-16
US10787643B2 (en) 2020-09-29
EP2148569A4 (en) 2011-02-16
EP2148569A1 (en) 2010-02-03
US20120309088A1 (en) 2012-12-06
US20130252338A1 (en) 2013-09-26
US8263403B2 (en) 2012-09-11
US20180072991A1 (en) 2018-03-15
US20100196337A1 (en) 2010-08-05
US20160355784A1 (en) 2016-12-08
US9771559B2 (en) 2017-09-26
US20150344845A1 (en) 2015-12-03
US8476071B2 (en) 2013-07-02
EP2148569B1 (en) 2014-07-16

Similar Documents

Publication Publication Date Title
JP2014195464A (ja) 幹細胞自己複製のための方法及び組成物
Hur et al. CD82/KAI1 maintains the dormancy of long-term hematopoietic stem cells through interaction with DARC-expressing macrophages
Lévesque et al. The endosteal ‘osteoblastic’niche and its role in hematopoietic stem cell homing and mobilization
Butler et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells
JP2023171952A (ja) 細胞集団を増大させるための方法および組成物
US9896659B2 (en) Methods, kits, and compositions for stem cell self-renewal
JP2022113722A (ja) ヒト造血幹/前駆細胞のエクスビボ拡大のための組成物および方法
KR101218663B1 (ko) 줄기세포 및 전구세포 분화의 조절, 측정 및 이들의 용도
Famili et al. Discrete roles of canonical and non-canonical Wnt signaling in hematopoiesis and lymphopoiesis
JP6669762B2 (ja) 移植後の造血幹細胞の生着効率の増進に使用するための組成物
US20050158857A1 (en) Hematopoietic stem cell identification and isolation
WO2010138873A1 (en) Long term expansion of human hematopoietic stem cells
Semedo et al. Targeting the bone marrow niche, moving towards leukemia eradication
WO2019147916A1 (en) Methods and system of human hemogenic reprogramming
Deutsch et al. Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte‐progenitor cells from cord blood
CN110551688A (zh) 一种诱导体细胞重编程为造血干/祖细胞且促进造血干/祖细胞体外扩增的组合物及其应用
Casetti New roles of STAT5 factors in chronic myeloid leukemia cell maintenance
Zerbst An investigation into the role of autophagy in mediating leukaemic cell location in the bone marrow niche
Dhami Identifying novel drug therapies for acute myeloid leukaemia by targeting the interactions between leukaemia cells and bone marrow microenvironment
Halvarsson Hypoxia-inducible factor 1 alpha-dependent and independent regulation of hematopoietic stem cells and leukemia
Tanaskovic Lack of p21 expression in tumor-associated APCs triggers the activation of a potent anti-tumor immune response
Luo The role of endoplasmic reticulum chaperones in regulating hematopoietic stem cells and hematological malignancies
HK40031696A (en) Methods and compositions for expansion of cell population
HK40031696B (en) Methods and compositions for expansion of cell population
Al Ajmi Role of oxidative stress and telomerase on haematopoietic stem and progenitor cell ageing

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110425

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110425

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120322

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130326

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130626

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140618

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20140818

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141007

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141106

R150 Certificate of patent or registration of utility model

Ref document number: 5646990

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250